Research is crucial in tackling cancer, which is why the Department invests over £1.5 billion per year in health research through the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £133 million in 2023/24. Cancer is a major area of NIHR spend, reflecting its high priority.
In the financial year 2023/24, total NIHR spending on direct research awards on brain cancer was £2.1 million spent across 22 active studies, with a total lifetime value of £11.8 million. In the same year, our wider infrastructure investments, which enable the country’s leading experts to develop and deliver high-quality translational, clinical, and applied research funded by ourselves, charities, and industry partners, allowed an additional 1,107 people to participate in potentially life-changing brain cancer research in the National Health Service.
In addition to direct research awards, NIHR infrastructure funding enables the country’s leading experts to develop and deliver high-quality translational, clinical, and applied research supported by other funders. These investments allowed an additional 1,107 people to participate in potentially life-changing brain cancer research in in the NHS in the same period.
","originalAnswerText":"","comparableAnswerText":"","dateAnswerCorrected":null,"dateHoldingAnswer":null,"attachmentCount":0,"heading":"Brain Cancer: Research","attachments":[],"groupedQuestionsDates":[]},"links":[{"rel":"self","href":"/Questions/1754533","method":"GET"}]}